Company / Tangible Book Value per Share
Trevi Therapeutics, Inc. Tangible Book Value per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.98
FY2024
5-year range
$0.75 / $1.66
FY2020-FY2024
Trend
+17.2%
vs FY2023
Sector context
#157 of 209
Health Care
What the data says
Trevi Therapeutics, Inc.'s tangible book value per share of $0.98 is lower than 75% of companies in the Health Care sector (FY2024). Tangible Book Value per Share has fluctuated over the past 7 years, ranging from $-250.21 in FY2018 to $4.65 in FY2019.
Based on SEC 10-K filings.
0.98 in FY2024 with a 5-year CAGR of -26.8%.
Declined from $1.66 to $0.98 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +9.3%
- 5-Year CAGR
- -26.8%
- 10-Year CAGR
- -
Sector benchmark
-99.0% below sector average
Key checks
Key Insights
- In FY2024, tangible book value per share increased 17.2% year-over-year.
- Ranks #157 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
- Lowest tangible book value per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.98 | +17.2% |
| FY2023 | $0.83 | -49.9% |
| FY2022 | $1.66 | +122.7% |
| FY2021 | $0.75 | -50.5% |
| FY2020 | $1.51 | -67.5% |
| FY2019 | $4.65 | +101.9% |
| FY2018 | -$250.21 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026